Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Naltrexone effect on yohimbine response
NCT00000195Phase 2Withdrawn
- Sponsor
- Yale University
- Start
- Jan 1993
- Primary completion
- Jan 1998
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of naltrexone in opioid use disorder (OUD), sponsored by Yale University. Primary endpoint: Behavioral, physiological, neuroendocrine response to yohimbine. Planned start Jan 1993; status: withdrawn.
02
Drugs
naltrexone
03
Conditions
opioid use disorder (OUD)
Beyond the preview
Go deeper on NCT00000195.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00000195.